Diabetes and Dementia
Diabetes and Dementia
Published: October 2008
New views are emerging on the spectrum of neurological complications that are associated with diabetes. In addition to somatic and autonomic peripheral diabetic neuropathy, stroke and acute metabolic catastrophes, progressive end-organ damage to the brain is now recognised as a long-term complication of diabetes. This cerebral damage is manifested in impaired cognitive performance and subtle structural cerebral abnormalities. In addition, the risk of dementia is increased. This paper provides a brief overview on the relationship between diabetes and dementia.
Risk of Dementia in Diabetes
Both type 1 and type 2 diabetes mellitus are associated with cognitive performance impairments. In type 1 diabetes mellitus this is reflected in a mild to moderate slowing of mental speed and a diminished mental flexibility.1 In type 2 diabetes cognitive changes mainly affect learning and memory, mental flexibility and mental speed.2,3 Longitudinal population-based studies indicate that the rate of cognitive decline is accelerated in elderly subjects with type 2 diabetes.4 While the association between diabetes and these modest changes in cognition is now well established; the relationship between diabetes and dementia has been subject of debate.
Early studies on the relationship between diabetes and dementia suggested that: “diabetes and Alzheimer’s disease may not co-exist”.5 This suggestion was based on the observation that the prevalence of diabetes among patients with established Alzheimer’s disease was low. It is likely, however, that these early studies suffered from methodological limitations such as survival bias. Moreover, the possible effects of Alzheimer’s disease itself on glucose metabolism may have confounded the results.
- Brands AMA, Biessels GJ, De Haan EHF, et al., Diabetes Care (2005) 28: pp. 726–735.
- Awad N, Gagnon M, Messier C, J Clin Exp Neuropsychol (2004) 26: pp. 1,044–1,080.
- Allen KV, Frier BM, Strachan MWJ, Eur J Pharmacol (2004) 490: pp. 169–175.
- Cukierman T, Gerstein HC, Williamson JD, Diabetologia (2005) 48: pp. 2,460–2,469.
- Bucht G, Adolfsson R, Lithner F, Winblad B, Acta Med Scand (1983) 213: pp. 387–392.
- Biessels GJ, Staekenborg S, Brunner E, et al., Lancet Neurol (2006) 5: pp. 64–74.
- Craft S, Watson GS, Lancet Neurol (2004) 3: pp. 169–178.
- Frisoni GB, Scheltens P, Galluzzi S, et al., J Neurol Neurosurg Psychiatry (2003) 74: pp. 1,371–1,381.
- van Harten B, de Leeuw FE, Weinstein HC, et al., Diabetes Care (2006) 29: pp. 2,539–2,548.
- Manschot SM, Brands AM, van der GJ, et al., Diabetes (2006) 55: pp. 1,106–1,113.






